Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michiel Rienstra

Showing results (71-80 of 365) with videos related to

Pageof 37
Sort By:
European Heart Journal|August 8, 2019
Residual confounding in observational studies: new data from the old DIG trialEva M Boorsma, Michiel Rienstra, Dirk J van Veldhuisen, et al.
Heart Rhythm O2|January 11, 2024
Reducing inappropriate and unnecessary implantable cardioverter-defibrillator therapy: Is patient confirmation via a mobile application the solution?Alwin B P Noordman, Michiel Rienstra, Yuri Blaauw, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|March 9, 2018
Atrial fibrillation progression and outcome in patients with young-onset atrial fibrillationRuben R De With, Ernaldo G Marcos, Isabelle C Van Gelder, et al.
Pharmacoeconomics|March 21, 2026
The Cost Utility of Rhythm Control Treatment Sequences in Patients with Atrial Fibrillation: Anti-arrhythmic Drugs Versus Catheter AblationSimone Huygens, Matthijs Versteegh, Martin Hemels, et al.
Arrhythmia & Electrophysiology Review|July 4, 2018
Risk Factor Management in Atrial FibrillationAxel Brandes, Marcelle D Smit, Bao Oanh Nguyen, et al.
European Journal of Preventive Cardiology|January 10, 2017
The left atrium: An overlooked prognostic toolMariëlle Kloosterman, Michiel Rienstra, Harry J Crijns, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|October 27, 2025
Implementation of new concise care pathways into a software tool to detect and manage comorbidities in older patients with atrial fibrillation: the Horizon 2020 EHRA-PATHS projectRana Önder, Lien Desteghe, Eline Vandeput, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|January 1, 2016
Atrial reverse remodelling is associated with outcome of cardiac resynchronization therapyMariëlle Kloosterman, Michiel Rienstra, Bart A Mulder, et al.
European Journal of Heart Failure|August 18, 2012
Heart failure highlights in 2011B Daan Westenbrink, Kevin Damman, Michiel Rienstra, et al.
Journal of Cardiovascular Development and Disease|April 26, 2024
Sex Differences in Outcomes of Patients with an Implantable Cardioverter-Defibrillator for the Secondary Prevention of Sudden Cardiac DeathAlwin B P Noordman, Michiel Rienstra, Yuri Blaauw, et al.
Pageof 37

Showing results (71-80 of 365) with videos related to

Sort By:
Pageof 37
European Heart Journal|August 8, 2019
Residual confounding in observational studies: new data from the old DIG trialEva M Boorsma, Michiel Rienstra, Dirk J van Veldhuisen, et al.
Heart Rhythm O2|January 11, 2024
Reducing inappropriate and unnecessary implantable cardioverter-defibrillator therapy: Is patient confirmation via a mobile application the solution?Alwin B P Noordman, Michiel Rienstra, Yuri Blaauw, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|March 9, 2018
Atrial fibrillation progression and outcome in patients with young-onset atrial fibrillationRuben R De With, Ernaldo G Marcos, Isabelle C Van Gelder, et al.
Pharmacoeconomics|March 21, 2026
The Cost Utility of Rhythm Control Treatment Sequences in Patients with Atrial Fibrillation: Anti-arrhythmic Drugs Versus Catheter AblationSimone Huygens, Matthijs Versteegh, Martin Hemels, et al.
Arrhythmia & Electrophysiology Review|July 4, 2018
Risk Factor Management in Atrial FibrillationAxel Brandes, Marcelle D Smit, Bao Oanh Nguyen, et al.
European Journal of Preventive Cardiology|January 10, 2017
The left atrium: An overlooked prognostic toolMariëlle Kloosterman, Michiel Rienstra, Harry J Crijns, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|October 27, 2025
Implementation of new concise care pathways into a software tool to detect and manage comorbidities in older patients with atrial fibrillation: the Horizon 2020 EHRA-PATHS projectRana Önder, Lien Desteghe, Eline Vandeput, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|January 1, 2016
Atrial reverse remodelling is associated with outcome of cardiac resynchronization therapyMariëlle Kloosterman, Michiel Rienstra, Bart A Mulder, et al.
European Journal of Heart Failure|August 18, 2012
Heart failure highlights in 2011B Daan Westenbrink, Kevin Damman, Michiel Rienstra, et al.
Journal of Cardiovascular Development and Disease|April 26, 2024
Sex Differences in Outcomes of Patients with an Implantable Cardioverter-Defibrillator for the Secondary Prevention of Sudden Cardiac DeathAlwin B P Noordman, Michiel Rienstra, Yuri Blaauw, et al.
Pageof 37